These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 35466502)

  • 21. Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2.
    Elkateb AS; Nofal S; Ali SA; Atya HB
    Inflammation; 2023 Aug; 46(4):1493-1511. PubMed ID: 37171695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD.
    Zhang Z; Fu C; Liu J; Sai X; Qin C; Di T; Yang Y; Wu Y; Bian T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3347-3362. PubMed ID: 34934311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
    Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
    Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human mesenchymal stem cells derived exosomes improve ovarian function in chemotherapy-induced premature ovarian insufficiency mice by inhibiting ferroptosis through Nrf2/GPX4 pathway.
    Zhou Y; Huang J; Zeng L; Yang Q; Bai F; Mai Q; Deng K
    J Ovarian Res; 2024 Apr; 17(1):80. PubMed ID: 38622725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.
    Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M
    Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AdipoR1 Regulates Ionizing Radiation-Induced Ferroptosis in HCC cells through Nrf2/xCT Pathway.
    Feng H; Liu Y; Gan Y; Li M; Liu R; Liang Z; Liu L; Li L; Chen H; Li G; Tian Z; Liu X; Ma S
    Oxid Med Cell Longev; 2022; 2022():8091464. PubMed ID: 35733794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis.
    Soutto M; Zhang X; Bhat N; Chen Z; Zhu S; Maacha S; Genoula M; El-Gazzaz O; Peng D; Lu H; McDonald OG; Chen XS; Cao L; Xu Z; El-Rifai W
    Redox Biol; 2024 Feb; 69():102998. PubMed ID: 38154380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
    Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
    Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Berberine inhibits erastin-induced ferroptosis of mouse hippocampal neuronal cells possibly by activating the Nrf2-HO-1/GPX4 pathway].
    Huang Q; Ji D; Tian X; Ma L; Sun X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):937-943. PubMed ID: 35790446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
    Wen RJ; Dong X; Zhuang HW; Pang FX; Ding SC; Li N; Mai YX; Zhou ST; Wang JY; Zhang JF
    Phytomedicine; 2023 Jul; 116():154881. PubMed ID: 37209607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sophoridine suppresses lenvatinib-resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression.
    Zhao Z; Zhang D; Wu F; Tu J; Song J; Xu M; Ji J
    J Cell Mol Med; 2021 Jan; 25(1):549-560. PubMed ID: 33210432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells.
    Kim DH; Kim WD; Kim SK; Moon DH; Lee SJ
    Cell Death Dis; 2020 May; 11(5):406. PubMed ID: 32471991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma.
    Myojin Y; Kodama T; Maesaka K; Motooka D; Sato Y; Tanaka S; Abe Y; Ohkawa K; Mita E; Hayashi Y; Hikita H; Sakamori R; Tatsumi T; Taguchi A; Eguchi H; Takehara T
    Clin Cancer Res; 2021 Feb; 27(4):1150-1161. PubMed ID: 33288659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Nrf2 inhibits ferroptosis and protects against oxaliplatin-induced ototoxicity.
    Xu K; Chang X; Bai X; Liu HB; Chen XB; Chen HP; Liu YH
    Biomed Pharmacother; 2023 Sep; 165():115248. PubMed ID: 37523980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression.
    Fu R; Jiang S; Li J; Chen H; Zhang X
    Med Oncol; 2020 Mar; 37(4):24. PubMed ID: 32166604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engeletin alleviates erastin-induced oxidative stress and protects against ferroptosis via Nrf2/Keap1 pathway in bone marrow mesenchymal stem cells.
    Huang L; Bian M; Lu S; Wang J; Yu J; Jiang L; Zhang J
    Tissue Cell; 2023 Jun; 82():102040. PubMed ID: 36857798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YT521-B homology domain containing 1 ameliorates mitochondrial damage and ferroptosis in sleep deprivation by activating the sirtuin 1/nuclear factor erythroid-derived 2-like 2/heme oxygenase 1 pathway.
    Chen J; Xiao L; Chen Y; Li W; Liu Y; Zhou Y; Tan H
    Brain Res Bull; 2023 Jun; 197():1-12. PubMed ID: 36935054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines
    Ogasawara S; Mihara Y; Kondo R; Kusano H; Akiba J; Yano H
    Anticancer Res; 2019 Nov; 39(11):5973-5982. PubMed ID: 31704822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.